Image de couverture de livre

Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Anna Gryglas‐Dworak, Jack Schim, Anders Ettrup, Line Pickering Boserup, Mette Krog Josiassen, Kristina Ranc, Bjørn Sperling, Messoud Ashina
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Headache: The Journal of Head and Face Pain
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
par: Andrew Blumenfeld, et autres
Publié: (2024)

No differences in subcortical volume between people with and without migraine: A REFORM study
par: Basit Ali Chaudhry, et autres
Publié: (2025)

The impact of headache intensity on speech in participants with migraine and acute post‐traumatic headache
par: Dani C. Smith, et autres
Publié: (2024)

What's in the pipeline for pediatric headache treatment?
par: Amy A. Gelfand, et autres
Publié: (2025)

Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
par: Christopher C. Anderson, et autres
Publié: (2024)

Chronotype in migraine and tension‐type headache: A population study
par: Da Eun Jung, et autres
Publié: (2026)

Magnetoencephalography studies in migraine and headache disorders: A systematic review
par: Raghavan Gopalakrishnan, et autres
Publié: (2024)

Flexible modeling of headache frequency fluctuations in migraine with hidden Markov models
par: Gina M. Dumkrieger, et autres
Publié: (2024)

Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral pharmacotherapies
par: Jennifer Robblee, et autres
Publié: (2024)

Integrating gepants into clinical practice for the acute treatment of migraine
par: Richard B. Lipton, et autres
Publié: (2026)

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
par: Alexander Yoo, et autres
Publié: (2025)

Readability analysis and concept mapping of PROMs used for headache disorders
par: Merel H. J. Hazewinkel, et autres
Publié: (2024)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
par: Jessica Ailani, et autres
Publié: (2024)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
par: Susan Hutchinson, et autres
Publié: (2026)

Microneedles for the treatment of migraine and orofacial pain: A narrative review
par: Baicheng Cao, et autres
Publié: (2026)

Evaluating patient and family preferences for acute and preventive pediatric headache treatment
par: Elise G. Martin, et autres
Publié: (2024)

Transcutaneous electrical nerve stimulation of the occipital nerves as treatment for chronic cluster headache
par: Ida Stisen Fogh‐Andersen, et autres
Publié: (2024)

Delayed urticaria during treatment with anti‐ CGRP monoclonal antibodies in migraine
par: Christoph T. Berger, et autres
Publié: (2026)

A study of migraine‐like headache caused by topical aryl hydrocarbon receptor agonist tapinarof
par: Toshiyuki Hikita, et autres
Publié: (2026)

Youth with high‐frequency headaches due to migraine are more vulnerable to non‐cephalic pain complaints
par: Brooke L. Reidy, et autres
Publié: (2025)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
par: Shuu‐Jiun Wang, et autres
Publié: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
par: Chia‐Chun Chiang, et autres
Publié: (2024)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
par: Andrea M. Kuczynski, et autres
Publié: (2025)

Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study
par: Maggie R. Mittleman, et autres
Publié: (2024)

Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities—A cross‐sectional study
par: Kuang‐Heng Lee, et autres
Publié: (2025)

Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo‐controlled clinical trials
par: Larry Charleston, et autres
Publié: (2026)

Comfort matters: A new strategy to ease injection pain during headache treatment procedures
par: Hannah F. J. Shapiro
Publié: (2026)

OnabotulinumtoxinA as a promising treatment for primary trochlear headache: A retrospective case series
par: Alex Jaimes, et autres
Publié: (2024)

American Headache Society white paper on treatment of post‐traumatic headache from concussion in youth
par: Carlyn Patterson Gentile, et autres
Publié: (2024)

Preliminary prospective observational investigation of clinical outcomes among treatment‐seeking youth with continuous headache
par: Robert C. Gibler, et autres
Publié: (2024)

Metaphorical use of “headache” and “migraine” in media: A longitudinal study of 1.3 million articles in major publications
par: Pengfei Zhang, et autres
Publié: (2024)

A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine ( TEAM) study
par: Gregory A. Panza, et autres
Publié: (2024)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
par: Richard B. Lipton, et autres
Publié: (2025)

Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment
par: Joanna K. Bougie, et autres
Publié: (2024)

Do patients with migraine and obesity receive different treatments? Insights from real‐world data
par: Keshet Pardo, et autres
Publié: (2025)

Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review
par: Stephen Silberstein, et autres
Publié: (2026)

The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model
par: Philip Victor Reducha, et autres
Publié: (2024)

Exploring the impact of acute SARS‐CoV‐2 infection on headache pattern in patients with migraine: A novel Bayesian analysis
par: Jiunn‐Tyng Yeh, et autres
Publié: (2025)

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department
par: Geneviève Tourigny‐Ruel, et autres
Publié: (2026)

A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache
par: Genaro G. Gutierrez, et autres
Publié: (2025)